HOME / Insights

GeneGoCell Insights

Stay informed, stay productive with all the latest from GeneGoCell.

Evidence Before Hope: Safety, Ethics, Independent Verification, and Public Education in Genome Editing

Evidence Before Hope: Safety, Ethics, Independent Verification, and Public Education in Genome Editing

By Dr. Elizabeth Yan Zhang, CMQ/OE, MBA, PhD, Founder and CEO, GeneGoCell on July 27, 2026

Genome editing requires rigorous safety data, ethical oversight, independent verification, transparent reporting, and accessible public education before clinical translation.
High-Resolution, Customizable, and Cost-Effective: Genome Editing Verification (GEV℠) G-Amp℠ Workflow Delivers It All

High-Resolution, Customizable, and Cost-Effective: Genome Editing Verification (GEV℠) G-Amp℠ Workflow Delivers It All

By Dr. Aaron Zhang-Chen, CQA, PhD on July 21, 2026

Discover how GeneGoCell's Genome Editing Verification (GEV℠) G-Amp℠ platform improves multiplex targeted amplicon sequencing with dual-amplicon, UMI technology for accurate, sensitive, and cost-effective NGS analysis of gene editing outcomes.
G-Screen℠ High-Throughput NGS Clone Genotyping

G-Screen℠ High-Throughput NGS Clone Genotyping

By Dr. Aaron Zhang-Chen, CQA, PhD on July 14, 2026

G-Screen℠ delivers fast, accurate high-throughput single cell clone genotyping via NGS for CGT developers and cell line engineering. Used in Cas-CLOVER gene editing studies. Accelerate clone selection and talk to us today.